Cargando…
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individual...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399604/ https://www.ncbi.nlm.nih.gov/pubmed/36033811 http://dx.doi.org/10.3389/fpubh.2022.967311 |
_version_ | 1784772561703272448 |
---|---|
author | Lin, Bin Hu, Yangmin Xu, Ping Xu, Tao Chen, Chunyan He, Le Zhou, Mi Chen, Zhangzhang Zhang, Chunhong Yu, Xuben Fang, Luo Zhu, Junfeng Ji, Yanlan Lin, Qun Cao, Hengbin Dai, Youqin Lu, Xiaoyan Shi, Changcheng Li, Li Wang, Changjiang Li, Xumei Fang, Qiongyan Miao, Jing Zhu, Zhengyi Lin, Guangyong Zhan, Haichao Lv, Shiwen Zhu, Yalan Cai, Xinjun Ying, Yin Chen, Meng Xu, Qiong Zhang, Yiwen Xu, Yubin Federico, Pea Jiang, Saiping Dai, Haibin |
author_facet | Lin, Bin Hu, Yangmin Xu, Ping Xu, Tao Chen, Chunyan He, Le Zhou, Mi Chen, Zhangzhang Zhang, Chunhong Yu, Xuben Fang, Luo Zhu, Junfeng Ji, Yanlan Lin, Qun Cao, Hengbin Dai, Youqin Lu, Xiaoyan Shi, Changcheng Li, Li Wang, Changjiang Li, Xumei Fang, Qiongyan Miao, Jing Zhu, Zhengyi Lin, Guangyong Zhan, Haichao Lv, Shiwen Zhu, Yalan Cai, Xinjun Ying, Yin Chen, Meng Xu, Qiong Zhang, Yiwen Xu, Yubin Federico, Pea Jiang, Saiping Dai, Haibin |
author_sort | Lin, Bin |
collection | PubMed |
description | Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective professional fields, we have formed this expert consensus. Our team of specialists is a multidisciplinary team that includes pharmacotherapists, clinical pharmacology specialists, critical care medicine specialists, respiratory specialists, infectious disease specialists, emergency medicine specialists and more. We are committed to the safe and effective use of linezolid in patients in need, and the promotion of its therapeutic drug monitoring. |
format | Online Article Text |
id | pubmed-9399604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93996042022-08-25 Expert consensus statement on therapeutic drug monitoring and individualization of linezolid Lin, Bin Hu, Yangmin Xu, Ping Xu, Tao Chen, Chunyan He, Le Zhou, Mi Chen, Zhangzhang Zhang, Chunhong Yu, Xuben Fang, Luo Zhu, Junfeng Ji, Yanlan Lin, Qun Cao, Hengbin Dai, Youqin Lu, Xiaoyan Shi, Changcheng Li, Li Wang, Changjiang Li, Xumei Fang, Qiongyan Miao, Jing Zhu, Zhengyi Lin, Guangyong Zhan, Haichao Lv, Shiwen Zhu, Yalan Cai, Xinjun Ying, Yin Chen, Meng Xu, Qiong Zhang, Yiwen Xu, Yubin Federico, Pea Jiang, Saiping Dai, Haibin Front Public Health Public Health Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective professional fields, we have formed this expert consensus. Our team of specialists is a multidisciplinary team that includes pharmacotherapists, clinical pharmacology specialists, critical care medicine specialists, respiratory specialists, infectious disease specialists, emergency medicine specialists and more. We are committed to the safe and effective use of linezolid in patients in need, and the promotion of its therapeutic drug monitoring. Frontiers Media S.A. 2022-08-10 /pmc/articles/PMC9399604/ /pubmed/36033811 http://dx.doi.org/10.3389/fpubh.2022.967311 Text en Copyright © 2022 Lin, Hu, Xu, Xu, Chen, He, Zhou, Chen, Zhang, Yu, Fang, Zhu, Ji, Lin, Cao, Dai, Lu, Shi, Li, Wang, Li, Fang, Miao, Zhu, Lin, Zhan, Lv, Zhu, Cai, Ying, Chen, Xu, Zhang, Xu, Federico, Jiang and Dai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Lin, Bin Hu, Yangmin Xu, Ping Xu, Tao Chen, Chunyan He, Le Zhou, Mi Chen, Zhangzhang Zhang, Chunhong Yu, Xuben Fang, Luo Zhu, Junfeng Ji, Yanlan Lin, Qun Cao, Hengbin Dai, Youqin Lu, Xiaoyan Shi, Changcheng Li, Li Wang, Changjiang Li, Xumei Fang, Qiongyan Miao, Jing Zhu, Zhengyi Lin, Guangyong Zhan, Haichao Lv, Shiwen Zhu, Yalan Cai, Xinjun Ying, Yin Chen, Meng Xu, Qiong Zhang, Yiwen Xu, Yubin Federico, Pea Jiang, Saiping Dai, Haibin Expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
title | Expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
title_full | Expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
title_fullStr | Expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
title_full_unstemmed | Expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
title_short | Expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
title_sort | expert consensus statement on therapeutic drug monitoring and individualization of linezolid |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399604/ https://www.ncbi.nlm.nih.gov/pubmed/36033811 http://dx.doi.org/10.3389/fpubh.2022.967311 |
work_keys_str_mv | AT linbin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT huyangmin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT xuping expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT xutao expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT chenchunyan expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT hele expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhoumi expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT chenzhangzhang expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhangchunhong expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT yuxuben expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT fangluo expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhujunfeng expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT jiyanlan expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT linqun expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT caohengbin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT daiyouqin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT luxiaoyan expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT shichangcheng expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT lili expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT wangchangjiang expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT lixumei expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT fangqiongyan expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT miaojing expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhuzhengyi expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT linguangyong expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhanhaichao expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT lvshiwen expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhuyalan expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT caixinjun expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT yingyin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT chenmeng expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT xuqiong expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT zhangyiwen expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT xuyubin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT federicopea expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT jiangsaiping expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid AT daihaibin expertconsensusstatementontherapeuticdrugmonitoringandindividualizationoflinezolid |